Skip to main content
bioRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search
New Results

Variability in human drug metabolizing cytochrome P450 CYP2C9, CYP2C19 and CYP3A5 activities caused by genetic variations in cytochrome P450 oxidoreductase

Maria Natalia Rojas Velazquez, Shaheena Parween, Sameer S Udhane, View ORCID ProfileAmit V Pandey
doi: https://doi.org/10.1101/640540
Maria Natalia Rojas Velazquez
1Pediatric Endocrinology, University Children’s Hospital, Bern, Switzerland
2Department of Biomedical Research, University of Bern, Bern, Switzerland
3Laboratorio de Genética Molecular, Departamento de Genética, Instituto de Investigaciones en Ciencias de la Salud, Universidad Nacional de Asunción, Campus San Lorenzo, Central, Paraguay
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Shaheena Parween
1Pediatric Endocrinology, University Children’s Hospital, Bern, Switzerland
2Department of Biomedical Research, University of Bern, Bern, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sameer S Udhane
1Pediatric Endocrinology, University Children’s Hospital, Bern, Switzerland
2Department of Biomedical Research, University of Bern, Bern, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Amit V Pandey
1Pediatric Endocrinology, University Children’s Hospital, Bern, Switzerland
2Department of Biomedical Research, University of Bern, Bern, Switzerland
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Amit V Pandey
  • For correspondence: amit@pandeylab.org
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Preview PDF
Loading

Abstract

A broad spectrum of human diseases are caused by mutations in the NADPH cytochrome P450 oxidoreductase (POR). Cytochrome P450 proteins perform several reactions, including the metabolism of steroids, drugs, and other xenobiotics. In 2004 the first human patients with defects in POR were reported, and over 250 variations in POR are known. Information about the effects of POR variants on drug metabolizing enzymes is limited and has not received much attention. By analyzing the POR sequences from genomics databases, we identified potentially disease-causing variations and characterized these by in vitro functional studies using recombinant proteins. Proteins were expressed in bacteria and purified for activity assays. Activities of cytochrome P450 enzymes were tested in vitro using liposomes prepared with lipids into which P450 and P450 reductase proteins were embedded. Here we are reporting the effect of POR variants on drug metabolizing enzymes CYP2C9, CYP2C19, and CYP3A5 which are responsible for the metabolism of many drugs. POR Variants A115V, T142A, A281T, P284L, A287P, and Y607C inhibited activities of all P450 proteins tested. Interestingly, the POR variant Q153R showed a reduction of 20-50% activities with CYP2C9 and CYP2C19 but had a 400% increased activity with CYP3A5. The A287P is most common POR mutation found in patients of European origin, and significantly inhibited drug metabolism activities which has important consequences for monitoring and treatment of patients. In vitro, functional assays using recombinant proteins provide a useful model for establishing the metabolic effect of genetic mutations. Our results indicate that detailed knowledge about POR variants is necessary for correct diagnosis and treatment options for persons with POR deficiency and the role of changes in drug metabolism and toxicology due to variations in POR needs to be addressed.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Back to top
PreviousNext
Posted May 17, 2019.
Download PDF
Email

Thank you for your interest in spreading the word about bioRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Variability in human drug metabolizing cytochrome P450 CYP2C9, CYP2C19 and CYP3A5 activities caused by genetic variations in cytochrome P450 oxidoreductase
(Your Name) has forwarded a page to you from bioRxiv
(Your Name) thought you would like to see this page from the bioRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Variability in human drug metabolizing cytochrome P450 CYP2C9, CYP2C19 and CYP3A5 activities caused by genetic variations in cytochrome P450 oxidoreductase
Maria Natalia Rojas Velazquez, Shaheena Parween, Sameer S Udhane, Amit V Pandey
bioRxiv 640540; doi: https://doi.org/10.1101/640540
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Variability in human drug metabolizing cytochrome P450 CYP2C9, CYP2C19 and CYP3A5 activities caused by genetic variations in cytochrome P450 oxidoreductase
Maria Natalia Rojas Velazquez, Shaheena Parween, Sameer S Udhane, Amit V Pandey
bioRxiv 640540; doi: https://doi.org/10.1101/640540

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Pharmacology and Toxicology
Subject Areas
All Articles
  • Animal Behavior and Cognition (2540)
  • Biochemistry (4990)
  • Bioengineering (3492)
  • Bioinformatics (15264)
  • Biophysics (6922)
  • Cancer Biology (5415)
  • Cell Biology (7762)
  • Clinical Trials (138)
  • Developmental Biology (4551)
  • Ecology (7175)
  • Epidemiology (2059)
  • Evolutionary Biology (10252)
  • Genetics (7527)
  • Genomics (9818)
  • Immunology (4884)
  • Microbiology (13278)
  • Molecular Biology (5159)
  • Neuroscience (29538)
  • Paleontology (203)
  • Pathology (840)
  • Pharmacology and Toxicology (1469)
  • Physiology (2149)
  • Plant Biology (4772)
  • Scientific Communication and Education (1015)
  • Synthetic Biology (1340)
  • Systems Biology (4017)
  • Zoology (770)